Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The nondrug is intended to improve the ability of children to pay attention, stay focused and control their behavior.
Tests like the one approved this week can show who is likely to be immune, but it’s not yet clear how long such immunity lasts.
Children are exposed to controlled amounts of Palforzia until they can tolerate the dosage needed to avoid severe allergic reactions.
Acting Commissioner Ned Sharpless will return to lead the National Cancer Institute.
AACR report highlights progress in preventing and treating cancer—including 27 new drug approvals last year—but disparities persist.
Off-label drug use for respiratory infections, asthma or mental health disorders in children is on the rise.
Pretomanid triple therapy cuts the length of treatment from 18 months to six months.
Previously, tests were approved only for use with genital or urine samples.
Eighty percent of medications that receive accelerated approval don’t extend overall survival.
Imbruvica plus Gazyva is the first chemotherapy-free regimen for chronic lymphocytic leukemia.
Four out of 10 FDA workers are sidelined.
Human papillomavirus vaccine can prevent cervical, anal and oral cancers.
Lucemyra is approved to treat the symptoms of opioid withdrawal for 14 days.
The FDA commissioner wants drugmakers to “end the shenanigans.”
New treatment approaches target tumors with shared characteristics, regardless of where they appear in the body.
Mike Sauers works for the U.S. Food and Drug Administration, and is one of more than 79,000 individuals who make HHS run every day.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.